These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 22925564

  • 1. In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer.
    Fahham D, Weiss ID, Abraham M, Beider K, Hanna W, Shlomai Z, Eizenberg O, Zamir G, Izhar U, Shapira OM, Peled A, Wald O.
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1167-1175.e1. PubMed ID: 22925564
    [Abstract] [Full Text] [Related]

  • 2. Targeting the CD20 and CXCR4 pathways in non-hodgkin lymphoma with rituximab and high-affinity CXCR4 antagonist BKT140.
    Beider K, Ribakovsky E, Abraham M, Wald H, Weiss L, Rosenberg E, Galun E, Avigdor A, Eizenberg O, Peled A, Nagler A.
    Clin Cancer Res; 2013 Jul 01; 19(13):3495-507. PubMed ID: 23637121
    [Abstract] [Full Text] [Related]

  • 3. Antitumor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung cancer.
    Xie CY, Xu YP, Jin W, Lou LG.
    Anticancer Drugs; 2012 Aug 01; 23(7):698-705. PubMed ID: 22441567
    [Abstract] [Full Text] [Related]

  • 4. Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma.
    Carter CA, Chen C, Brink C, Vincent P, Maxuitenko YY, Gilbert KS, Waud WR, Zhang X.
    Cancer Chemother Pharmacol; 2007 Feb 01; 59(2):183-95. PubMed ID: 16724239
    [Abstract] [Full Text] [Related]

  • 5. Effects of polyphyllin I on growth inhibition of human non-small lung cancer cells and in xenograft.
    Kong M, Fan J, Dong A, Cheng H, Xu R.
    Acta Biochim Biophys Sin (Shanghai); 2010 Nov 01; 42(11):827-33. PubMed ID: 20978038
    [Abstract] [Full Text] [Related]

  • 6. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
    Chan DC, Gera L, Stewart JM, Helfrich B, Zhao TL, Feng WY, Chan KK, Covey JM, Bunn PA.
    Clin Cancer Res; 2002 May 01; 8(5):1280-7. PubMed ID: 12006549
    [Abstract] [Full Text] [Related]

  • 7. Combination of imatinib with CXCR4 antagonist BKT140 overcomes the protective effect of stroma and targets CML in vitro and in vivo.
    Beider K, Darash-Yahana M, Blaier O, Koren-Michowitz M, Abraham M, Wald H, Wald O, Galun E, Eizenberg O, Peled A, Nagler A.
    Mol Cancer Ther; 2014 May 01; 13(5):1155-69. PubMed ID: 24502926
    [Abstract] [Full Text] [Related]

  • 8. Paclitaxel-octreotide conjugates in tumor growth inhibition of A549 human non-small cell lung cancer xenografted into nude mice.
    Shen H, Hu D, Du J, Wang X, Liu Y, Wang Y, Wei JM, Ma D, Wang P, Li L.
    Eur J Pharmacol; 2008 Dec 28; 601(1-3):23-9. PubMed ID: 18983839
    [Abstract] [Full Text] [Related]

  • 9. Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer.
    Ye S, Yang W, Wang Y, Ou W, Ma Q, Yu C, Ren J, Zhong G, Shi H, Yuan Z, Su X, Zhu W.
    Int J Mol Med; 2013 Jan 28; 31(1):33-42. PubMed ID: 23128378
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies.
    Xue X, Sun DF, Sun CC, Liu HP, Yue B, Zhao CR, Lou HX, Qu XJ.
    Lung Cancer; 2012 Jun 28; 76(3):300-8. PubMed ID: 22261315
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK, Meeran SM, Katiyar N, Akhtar S.
    Mol Carcinog; 2009 Jan 28; 48(1):24-37. PubMed ID: 18459128
    [Abstract] [Full Text] [Related]

  • 14. Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: role in non-small cell lung cancer tumor proliferation.
    Wald O, Izhar U, Amir G, Kirshberg S, Shlomai Z, Zamir G, Peled A, Shapira OM.
    J Thorac Cardiovasc Surg; 2011 Jun 28; 141(6):1503-12. PubMed ID: 21463876
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of mTOR by temsirolimus contributes to prolonged survival of mice with pleural dissemination of non-small-cell lung cancer cells.
    Ohara T, Takaoka M, Toyooka S, Tomono Y, Nishikawa T, Shirakawa Y, Yamatsuji T, Tanaka N, Fujiwara T, Naomoto Y.
    Cancer Sci; 2011 Jul 28; 102(7):1344-9. PubMed ID: 21521416
    [Abstract] [Full Text] [Related]

  • 16. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M, Benzo A, Irrissuto C, Lopez G, Curatella B, Maggi CA, Manzini S, Crea A, Caroli S, Cubadda F, Binaschi M.
    Cancer Chemother Pharmacol; 2008 Sep 28; 62(4):621-9. PubMed ID: 18038274
    [Abstract] [Full Text] [Related]

  • 17. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
    Su L, Zhang J, Xu H, Wang Y, Chu Y, Liu R, Xiong S.
    Clin Cancer Res; 2005 Dec 01; 11(23):8273-80. PubMed ID: 16322285
    [Abstract] [Full Text] [Related]

  • 18. Cyclooxygenase-2 inhibitor, nimesulide, improves radiation treatment against non-small cell lung cancer both in vitro and in vivo.
    Grimes KR, Warren GW, Fang F, Xu Y, St Clair WH.
    Oncol Rep; 2006 Oct 01; 16(4):771-6. PubMed ID: 16969492
    [Abstract] [Full Text] [Related]

  • 19. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
    Xie S, Tu Z, Xiong J, Kang G, Zhao L, Hu W, Tan H, Tembo KM, Ding Q, Deng X, Huang J, Zhang Q.
    Oncol Rep; 2017 Feb 01; 37(2):921-928. PubMed ID: 27922681
    [Abstract] [Full Text] [Related]

  • 20. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
    Chattopadhyay S, Machado-Pinilla R, Manguan-García C, Belda-Iniesta C, Moratilla C, Cejas P, Fresno-Vara JA, de Castro-Carpeño J, Casado E, Nistal M, Gonzalez-Barón M, Perona R.
    Oncogene; 2006 Jun 01; 25(23):3335-45. PubMed ID: 16462770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.